EDMONTON, ALBERTA--(Marketwire - September 25, 2007) - Ceapro Inc. (TSX VENTURE: CZO) (“Ceapro” or the “Corporation”) In conjunction with the recent appointments to the Ceapro Board of Gilles Gagnon and Glenn Rourke, Ceapro announces that it will, subject to the approval of the TSX Venture Exchange, issue 150,000 stock options to each of Messrs Gagnon and Rourke. Each of these options, which vest in five equal annual instalments commencing on the date of issue, entitle the holder to acquire one common share upon payment of the exercise price of CAD$0.28, representing the closing price on September 24th Each option, upon vesting but subject to prior termination, is exercisable for a period of five years.
